The first in-human Phase I study of a BET inhibitor for the treatment of NHL
Ibrutinib vs temsirolimus in relapsed/refractory mantle cell lymphoma
What is the role of allogeneic stem cell transplantation in CLL in the light of novel drugs?
Overview of 3 studies on CLL therapy: data on ibrutinib and a ROR1 inhibitor
How to manage infections after hematopoietic stem cell transplantation and the issue of resistance